These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 2684075)
21. Metoclopramide-associated tardive dyskinesia in hemodialysis patients with diabetes mellitus. Two case reports. Sewell DD; Yoshinobu BH; Caligiuri MP; Jeste DV Gen Hosp Psychiatry; 1992 Nov; 14(6):416-9. PubMed ID: 1473712 [TBL] [Abstract][Full Text] [Related]
22. Treatment of tardive dyskinesia with levetiracetam in a transplant patient. Zivković SA; Costa G; Bond G; Abu-Elmagd KM Acta Neurol Scand; 2008 May; 117(5):351-3. PubMed ID: 17995990 [TBL] [Abstract][Full Text] [Related]
23. Metoclopramide-induced tardive dyskinesia: a case report. Lazzara RR; Stoudemire A; Manning D; Prewitt KC Gen Hosp Psychiatry; 1986 Mar; 8(2):107-9. PubMed ID: 3957014 [TBL] [Abstract][Full Text] [Related]
24. A case of tardive dyskinesia caused by metoclopramide. Indo T; Matsuoka Y Jpn J Med; 1984 May; 23(2):152-4. PubMed ID: 6727060 [TBL] [Abstract][Full Text] [Related]
25. [Iatrogenic extrapyramidal disorders]. Ludin HP Schweiz Med Wochenschr; 1990 Jun; 120(23):855-8. PubMed ID: 1972812 [TBL] [Abstract][Full Text] [Related]
27. Extrapyramidal side effects of antiemetics presenting as psychiatric illness. Rodgers C Gen Hosp Psychiatry; 1992 May; 14(3):192-5. PubMed ID: 1601295 [TBL] [Abstract][Full Text] [Related]
28. Tardive akathisia and agitated depression during metoclopramide therapy. Shearer RM; Bownes IT; Curran P Acta Psychiatr Scand; 1984 Nov; 70(5):428-31. PubMed ID: 6516892 [TBL] [Abstract][Full Text] [Related]
29. Drug Insight: from disturbed motility to disordered movement--a review of the clinical benefits and medicolegal risks of metoclopramide. Pasricha PJ; Pehlivanov N; Sugumar A; Jankovic J Nat Clin Pract Gastroenterol Hepatol; 2006 Mar; 3(3):138-48. PubMed ID: 16511548 [TBL] [Abstract][Full Text] [Related]
31. Movement disorders induced by psychiatric drugs that do not block dopamine receptors. Friedman JH Parkinsonism Relat Disord; 2020 Oct; 79():60-64. PubMed ID: 32871538 [TBL] [Abstract][Full Text] [Related]
32. [Severe parkinsonism due to metoclopramide: the importance of early recognition]. de Ronde MW; Kingma HJ; Munts AG Ned Tijdschr Geneeskd; 2013; 157(26):A6037. PubMed ID: 23835236 [TBL] [Abstract][Full Text] [Related]
33. Drug-induced movement disorders. Jiménez-Jiménez FJ; García-Ruiz PJ; Molina JA Drug Saf; 1997 Mar; 16(3):180-204. PubMed ID: 9098656 [TBL] [Abstract][Full Text] [Related]
34. Adverse effects of antipsychotic drugs. Malhotra AK; Litman RE; Pickar D Drug Saf; 1993 Dec; 9(6):429-36. PubMed ID: 7907481 [TBL] [Abstract][Full Text] [Related]
36. Movement disorders and depression due to flunarizine and cinnarizine. Micheli FE; Pardal MM; Giannaula R; Gatto M; Parera I; Paradiso G; Torres M; Pikielny R; Pardal J Mov Disord; 1989; 4(2):139-46. PubMed ID: 2733706 [TBL] [Abstract][Full Text] [Related]
37. Tardive dyskinesia associated with use of metoclopramide in a child. Putnam PE; Orenstein SR; Wessel HB; Stowe RM J Pediatr; 1992 Dec; 121(6):983-5. PubMed ID: 1447672 [TBL] [Abstract][Full Text] [Related]
38. Treating extrapyramidal reactions: some current issues. Gelenberg AJ J Clin Psychiatry; 1987 Sep; 48 Suppl():24-7. PubMed ID: 2887554 [TBL] [Abstract][Full Text] [Related]
39. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy. Bitton V; Melamed E J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157 [TBL] [Abstract][Full Text] [Related]